The Latest in Conference Coverage

Unresolved fatigue lingers for most PsA patients

July 17, 2017

Psoriasis

Children with psoriasis face multitude of comorbidities

July 15, 2017

Psoriasis

Ixekizumab helps PsA patients who failed a TNFi

July 14, 2017

Psoriasis

Comorbidities in psoriatic arthritis flag worse prognosis

July 8, 2017

Psoriasis

Early phase III data positive for adalimumab biosimilar, for both psoriasis and PsA

July 1, 2017

Psoriasis

Pain often persists despite biologic treatment in PsA

June 16, 2017

Psoriasis

Infliximab biosimilar noninferior to originator in IBD – NOR-SWITCH

May 23, 2017

Psoriasis

Some data support botulinum toxin for psoriasis and rosacea

May 1, 2017

Psoriasis

Pediatric psoriasis may have a distinct presentation

May 1, 2017

Psoriasis

How to get the most out of methotrexate for psoriasis

April 18, 2017

Psoriasis

What’s old is new in topical psoriasis therapy

April 5, 2017

Psoriasis

Ixekizumab found superior to ustekinumab in psoriasis at 24 weeks

March 22, 2017

Psoriasis

Clinicians still seek the best uses for apremilast

March 20, 2017

Psoriasis

Adalimumab for psoriasis: Blocking TNF-alpha had no effect on vascular inflammation

March 15, 2017

Psoriasis

VIDEO: Stress alleviation strategies boost inflammatory skin treatment regimens

March 11, 2017

Psoriasis